Implementation of Section 120 of the Food and Drug Administration Modernization Act of 1997-Advisory Committees
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 1, 1998
May 26, 2020
45b9b815-ce9c-4261-b77c-20e27647c07e
Related Documents
Variations in Drug Products that May Be Included in a Single ANDA
Guidance DocumentDecember 1, 1998Center for Drug Evaluation and Research
Standards for the Prompt Review of Efficacy Supplements, Including Priority Efficacy Supplements : Guidance for Industry
Guidance DocumentMay 1, 1998Center for Drug Evaluation and Research
180-Day Generic Drug Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
Guidance DocumentJune 1, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.